EQ
Equillium, Inc.
Key Financials
Operating Income
$-23634000
↓ 185.8%
Net Income
$-22398000
↓ 177.6%
EPS (Diluted)
$-0.39
↓ 69.6%
Revenue
$41.1M
0.0%
Shareholders' Equity
$28.6M
↑ 50.0%
Total Assets
$31.9M
↑ 24.5%
Long-term Debt
$9.1M
↓ 10.9%
Total Liabilities
$3.3M
↓ 49.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | EQ |
| Company Name | Equillium, Inc. |
| CIK | 1746466 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (858) 412-5302 |